Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Chang Y.,,Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers,2011,Annals of Surgical Oncology,39,10.1245/s10434-010-1295-6,Taiwan,Article,Taipei,0,Journal,2-s2.0-79951553839
Goldstein I.,,Understanding wild-type and mutant p53 activities in human cancer: New landmarks on the way to targeted therapies,2011,Cancer Gene Therapy,107,10.1038/cgt.2010.63,Israel,Review,Rehovot,1,Journal,2-s2.0-78650308849
Zhao C.,,Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA,2010,Cell Cycle,59,10.4161/cc.9.9.11545,Sweden,Article,Stockholm,1,Journal,2-s2.0-77953562379
Graziano S.L.,,Prognostic significance of mucin and P53 expression in stage ib non-small cell lung cancer: A laboratory companion study to CALGB 9633,2010,Journal of Thoracic Oncology,16,10.1097/JTO.0b013e3181d89f95,United States,Article,Albany,1,Journal,2-s2.0-77953174764
Robles A.I.,,Clinical outcomes and correlates of TP53 mutations and cancer.,2010,Cold Spring Harbor perspectives in biology,151,10.1101/cshperspect.a001016,United States,Review,Bethesda,1,Journal,2-s2.0-77955382651
Olivier M.,,"TP53 mutations in human cancers: origins, consequences, and clinical use.",2010,Cold Spring Harbor perspectives in biology,779,10.1101/cshperspect.a001008,France,Review,Lyon,1,Journal,2-s2.0-77955363995
Brosh R.,,When mutants gain new powers: News from the mutant p53 field,2009,Nature Reviews Cancer,698,10.1038/nrc2693,Israel,Review,Rehovot,0,Journal,2-s2.0-70349443284
Hainaut P.,,30 years and a long way into p53 research,2009,The Lancet Oncology,63,10.1016/S1470-2045(09)70198-6,France,Review,Lyon,0,Journal,2-s2.0-69149089025
Baumann M.,,Radiotherapy of lung cancer: Technology meets biology meets multidisciplinarity,2009,Radiotherapy and Oncology,21,10.1016/j.radonc.2009.05.001,,Editorial,,0,Journal,2-s2.0-65749092105
Pfeifer G.,,Mutational spectra of human cancer,2009,Human Genetics,125,10.1007/s00439-009-0657-2,United States,Review,Duarte,0,Journal,2-s2.0-67349165561
Gow C.,,Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer,2009,Annals of Oncology,171,10.1093/annonc/mdn679,Taiwan;Taiwan,Article,I-lan;Taipei,1,Journal,2-s2.0-63549140887
Custodio A.B.,,Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer,2009,Journal of Thoracic Oncology,30,10.1097/JTO.0b013e3181a4b8fb,Spain,Review,Madrid,1,Journal,2-s2.0-68549127070
Vazquez A.,,"The genetics of the p53 pathway, apoptosis and cancer therapy",2008,Nature Reviews Drug Discovery,492,10.1038/nrd2656,United States,Article,Princeton,0,Journal,2-s2.0-57049114832
Ding L.,,Somatic mutations affect key pathways in lung adenocarcinoma,2008,Nature,1868,10.1038/nature07423,United States,Article,St. Louis,1,Journal,2-s2.0-54549094903
Magrini R.,,PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells,2008,Journal of Cellular Biochemistry,22,10.1002/jcb.21794,Italy;Italy,Article,Genova;Siena,0,Journal,2-s2.0-49049096115
Subramanian J.,,Molecular genetics of lung cancer in people who have never smoked,2008,The Lancet Oncology,94,10.1016/S1470-2045(08)70174-8,United States,Review,St. Louis,0,Journal,2-s2.0-45849137072
Donzelli S.,,Oncogenomic approaches in exploring gain of function of mutant p53,2008,Current Genomics,17,10.2174/138920208784340713,Italy,Review,Roma,0,Journal,2-s2.0-46049118428
Kandioler D.,,Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer,2008,Journal of Thoracic and Cardiovascular Surgery,37,10.1016/j.jtcvs.2007.10.072,Austria,Article,Vienna,1,Journal,2-s2.0-43049093034
Riley T.,,Transcriptional control of human p53-regulated genes,2008,Nature Reviews Molecular Cell Biology,1293,10.1038/nrm2395,United States;United States,Article,Piscataway;Princeton,0,Journal,2-s2.0-42449114966
Hecht S.,,Progress and challenges in selected areas of tobacco carcinogenesis,2008,Chemical Research in Toxicology,212,10.1021/tx7002068,United States,Review,Minneapolis,0,Journal,2-s2.0-38949170926
Tsao M.,,Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non-small-cell lung cancer,2007,Journal of Clinical Oncology,235,10.1200/JCO.2007.12.6953,Canada,Article,Toronto,0,Journal,2-s2.0-36849041454
Soussi T.,,Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm,2007,Cancer Cell,261,10.1016/j.ccr.2007.10.001,Sweden;France,Review,Stockholm;Paris,1,Journal,2-s2.0-35148826938
Song H.,,Gain of function of p53 cancer mutants in disrupting critical DNA damage response pathways,2007,Cell Cycle,33,10.4161/cc.6.13.4456,United States,Review,San Diego,1,Journal,2-s2.0-34548257378
Petitjean A.,,Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database,2007,Human Mutation,1143,10.1002/humu.20495,France,Article,Lyon,1,Journal,2-s2.0-34248379012
Selivanova G.,,Reactivation of mutant p53: Molecular mechanisms and therapeutic potential,2007,Oncogene,142,10.1038/sj.onc.1210295,Sweden,Review,Stockholm,1,Journal,2-s2.0-34047209861
Petitjean A.,,TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes,2007,Oncogene,559,10.1038/sj.onc.1210302,France,Review,Lyon,1,Journal,2-s2.0-34047207337
Peart M.,,Mutant p53 gain of function: The NF-Y connection,2006,Cancer Cell,23,10.1016/j.ccr.2006.08.014,United States,Short Survey,New York,1,Journal,2-s2.0-33748168725
Wiman K.,,Strategies for therapeutic targeting of the p53 pathway in cancer,2006,Cell Death and Differentiation,118,10.1038/sj.cdd.4401921,Sweden,Note,Stockholm,0,Journal,2-s2.0-33646799132
Soussi T.,,Locus-specific mutation databases: Pitfalls and good practice based on the p53 experience,2006,Nature Reviews Cancer,113,10.1038/nrc1783,Sweden;France,Review,Stockholm;Paris,0,Journal,2-s2.0-30144433850
Soussi T.,,The p53 pathway and human cancer,2005,British Journal of Surgery,31,10.1002/bjs.5177,France;Sweden,Article,Paris;Stockholm,0,Journal,2-s2.0-27544445335
Viktorsson K.,,The role of p53 in treatment responses of lung cancer,2005,Biochemical and Biophysical Research Communications,114,10.1016/j.bbrc.2005.03.192,Sweden,Review,Stockholm,0,Journal,2-s2.0-18144429131
Bykov V.,,PRIMA-1<sup>MET</sup> synergizes with cisplatin to induce tumor cell apoptosis,2005,Oncogene,143,10.1038/sj.onc.1208419,Sweden,Article,Stockholm,1,Journal,2-s2.0-19444387176
Tyczynski J.,,Mortality from lung cancer and tobacco smoking in Ohio (U.S.): Will increasing smoking prevalence reverse current decreases in mortality?,2005,Cancer Epidemiology Biomarkers and Prevention,7,10.1158/1055-9965.EPI-04-0699,United States;United States,Article,Dayton;Dayton,1,Journal,2-s2.0-18544381394
Munro A.J.,,P53 abnormalities and outcomes in colorectal cancer: A systematic review,2005,British Journal of Cancer,222,10.1038/sj.bjc.6602358,United Kingdom,Review,Dundee,1,Journal,2-s2.0-15244362062
Parkin D.,,"Global cancer statistics, 2002",2005,Ca-A Cancer Journal for Clinicians,16508,10.3322/canjclin.55.2.74,France,Review,Lyon,0,Journal,2-s2.0-14944385553
Issaeva N.,,"Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors",2004,Nature Medicine,587,10.1038/nm1146,Sweden,Article,Solna,0,Journal,2-s2.0-11144315535
Tyczynski J.E.,,"Lung cancer mortality patterns in selected Central, Eastern and Southern European countries",2004,International Journal of Cancer,50,10.1002/ijc.20019,France,Article,Lyon,1,Journal,2-s2.0-1542719912
Leslie W.T.,,Novel treatments in non-small cell lung cancer,2004,Hematology/Oncology Clinics of North America,12,10.1016/S0889-8588(03)00146-1,United States,Review,Chicago,0,Journal,2-s2.0-1042287070
Olivier M.,,TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.,2004,IARC scientific publications,183,,United States,Review,Bethesda,0,Journal,2-s2.0-1842862755
Hofseth L.,,p53: 25 Years after its discovery,2004,Trends in Pharmacological Sciences,322,10.1016/j.tips.2004.02.009,United States;United States,Short Survey,Columbia;Bethesda,0,Journal,2-s2.0-1942517876
Olivier M.,,"Li-Fraumeni and Related Syndromes: Correlation between Tumor Type, Family Structure, and TP53 Genotype",2003,Cancer Research,340,,France,Article,Lyon,0,Journal,2-s2.0-0142157701
Toyooka S.,,"The TP53 gene, tobacco exposure, and lung cancer",2003,Human Mutation,218,10.1002/humu.10177,Japan;United States,Review,Okayama;Dallas,0,Journal,2-s2.0-0037220167
Tyczynski J.,,"Lung cancer in Europe in 2000: Epidemiology, prevention, and early detection",2003,Lancet Oncology,197,10.1016/S1470-2045(03)00960-4,France,Review,Lyon,0,Journal,2-s2.0-0037242138
Swisher S.,,Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy,2003,Clinical Cancer Research,202,,United States,Article,Houston,0,Journal,2-s2.0-12244298187
Vousden K.H.,,Live or let die: The cell's response to p53,2002,Nature Reviews Cancer,2519,10.1038/nrc864,United Kingdom;United States,Review,Glasgow;Frederick,0,Journal,2-s2.0-0036674617
Olivier M.,,The IARC TP53 database: New online mutation analysis and recommendations to users,2002,Human Mutation,941,10.1002/humu.10081,France,Review,Lyon,0,Journal,2-s2.0-0036258111
Vogt U.,,p53 gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer,2002,Journal of Cancer Research and Clinical Oncology,26,10.1007/s00432-001-0305-2,Germany,Article,Ibbenburen,0,Journal,2-s2.0-0036189873
Pfeifer G.,,"Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers",2002,Oncogene,726,10.1038/sj.onc.1205803,United States,Article,Duarte,1,Journal,2-s2.0-0037152628
Bykov V.,,Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound,2002,Nature Medicine,747,10.1038/nm0302-282,Sweden,Article,Stockholm,0,Journal,2-s2.0-0036128899
Jin S.,,The p53 functional circuit,2001,Journal of Cell Science,242,,United States,Editorial,New York,0,Journal,2-s2.0-0035211073
Hainaut P.,,TP53 mutation spectrum in lung cancers and mutagenic signature of compenents of tobacco smoke: Lessons from the IARC TP53 mutation database [1],2001,Mutagenesis,33,,France,Letter,Lyon,0,Journal,2-s2.0-0035171991
Vähäkangas K.,,p53 and K-ras mutations in lung cancers from former and never-smoking women,2001,Cancer Research,112,,Finland,Article,Oulu,0,Journal,2-s2.0-0035361397
Hainaut P.,,Patterns of p53→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke,2001,Carcinogenesis,315,,France,Article,Lyon,0,Journal,2-s2.0-0034745389
Steels E.,,Role of p53 as a prognostic factor for survival in lung cancer: A systematic review of the literature with a meta-analysis,2001,European Respiratory Journal,325,10.1183/09031936.01.00062201,Belgium,Article,Brussels,1,Journal,2-s2.0-17944380542
Sigal A.,,Oncogenic mutations of the p53 tumor suppressor: The demons of the guardian of the genome,2000,Cancer Research,540,,Israel,Review,Rehovot,0,Journal,2-s2.0-0034671945
Mitsudomi T.,,Prognostic significance of p53 alterations in patients with non-small cell lung cancer: A meta-analysis,2000,Clinical Cancer Research,267,,Japan,Article,Nagoya,0,Journal,2-s2.0-0033765491
Husgafvel-Pursiainen K.,,p53 Mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer,2000,Cancer Research,94,,Finland,Article,Helsinki,0,Journal,2-s2.0-0034213247
Smith L.,,Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons,2000,Journal of the National Cancer Institute,258,10.1093/jnci/92.10.803,United States,Article,Duarte,1,Journal,2-s2.0-0034679057
Perwez Hussain S.,,"p53 tumor suppressor gene: At the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment",2000,Annals of the New York Academy of Sciences,61,10.1111/j.1749-6632.2000.tb06870.x,United States,Conference Paper,Bethesda,0,Book Series,2-s2.0-0033695273
Weill D.,,Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection,2000,Chest,83,10.1378/chest.118.4.966,United States,Article,Houston,0,Journal,2-s2.0-0033785831
Nemunaitis J.,,Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer,2000,Journal of Clinical Oncology,308,10.1200/jco.2000.18.3.609,United States,Article,Houston,0,Journal,2-s2.0-0033950285
Vogelstein B.,,Surfing the p53 network,2000,Nature,5350,10.1038/35042675,United States,Article,Baltimore,0,Journal,2-s2.0-0034676455
Bennett W.,,"Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women",1999,Journal of the National Cancer Institute,147,10.1093/jnci/91.23.2009,United States;United States,Article,Bethesda;Duarte,1,Journal,2-s2.0-0033486094
Tammemagi M.,,Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers,1999,Cancer Epidemiology Biomarkers and Prevention,69,,United States;United States,Article,Detroit;Detroit,0,Journal,2-s2.0-0032803467
Swisher S.G.,,Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer,1999,Journal of the National Cancer Institute,437,10.1093/jnci/91.9.763,United States,Article,Houston,1,Journal,2-s2.0-0033526357
Gealy R.,,Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women,1999,Cancer Epidemiology Biomarkers and Prevention,94,,United States,Article,Pittsburgh,0,Journal,2-s2.0-0032954937
Hainaut P.,,p<sup>53</sup> and Human Cancer: The First Ten Thousand Mutations,1999,Advances in Cancer Research,793,10.1016/S0065-230X(08)60785-X,France,Article,Lyon,0,Book Series,2-s2.0-0033992478
Denissenko M.,,The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B<inf>1</inf> adducts,1998,Oncogene,77,10.1038/sj.onc.1202214,United States;United States,Article,Franklin Lakes;Duarte,1,Journal,2-s2.0-0032506782
Higashiyama M.,,Immunohistochemical p53 protein status in nonsmall cell lung cancer is a promising indicator in determining in vitro chemosensitivity to some anticancer drugs,1998,Journal of Surgical Oncology,21,10.1002/(SICI)1096-9098(199805)68:1<19::AID-JSO5>3.0.CO;2-O,Japan,Article,,0,Journal,2-s2.0-0031750262
Pomerantz J.,,"The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53",1998,Cell,1267,10.1016/S0092-8674(00)81400-2,United States,Article,New York,1,Journal,2-s2.0-0032549704
Zhang Y.,,ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways,1998,Cell,1328,10.1016/S0092-8674(00)81401-4,United States,Article,Chapel Hill,1,Journal,2-s2.0-0032549711
Hussain S.P.,,Molecular epidemiology of human cancer.,1998,Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer,27,10.1007/978-3-642-46870-4_2,United States,Review,Bethesda,0,Journal,2-s2.0-0032250537
Takagi Y.,,p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking,1998,British Journal of Cancer,29,10.1038/bjc.1998.258,Japan;Japan,Article,Nagoya;Gifu,1,Journal,2-s2.0-7144261700
Hernandez-Boussard T.,,A specific spectrum of p53 mutations in lung cancer from smokers: Review of mutations compiled in the IARC p53 database,1998,Environmental Health Perspectives,113,10.1289/ehp.98106385,France,Article,Lyon,1,Journal,2-s2.0-0031758362
Levine A.,,"p53, the cellular gatekeeper for growth and division",1997,Cell,6422,10.1016/S0092-8674(00)81871-1,United States,Review,Princeton,1,Journal,2-s2.0-0030941458
Hainaut P.,,Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects,1997,Nucleic Acids Research,273,10.1093/nar/25.1.151,France,Article,Lyon,1,Journal,2-s2.0-0030752030
Denissenko M.,,Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53,1996,Science,1435,10.1126/science.274.5286.430,United States,Article,Duarte,0,Journal,2-s2.0-0029806936
Roth J.,,Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer,1996,Nature Medicine,671,10.1038/nm0996-985,United States,Article,Houston,0,Journal,2-s2.0-9544244796
Harris C.,,p53 tumor suppressor gene: From the basic research laboratory to the clinic - An abridged historical perspective,1996,Carcinogenesis,229,10.1093/carcin/17.6.1187,United States,Review,Bethesda,1,Journal,2-s2.0-0029922621
Kondo K.,,A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients,1996,Journal of Surgical Oncology,57,10.1002/(SICI)1096-9098(199601)61:1<20::AID-JSO6>3.0.CO;2-U,Japan,Article,Tokushima,0,Journal,2-s2.0-0030021713
Rusch V.,,Aberrant p53 Expression Predicts Clinical Resistance to Cisplatin-based Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer,1995,Cancer Research,175,,United States,Article,New York,0,Journal,2-s2.0-0028840535
Sozzi G.,,Genetic Evidence for an Independent Origin of Multiple Preneoplastic and Neoplastic Lung Lesions,1995,Cancer Research,158,,Italy,Article,Milan,0,Journal,2-s2.0-0028959132
Fujiwara T.,,Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model,1994,Journal of the National Cancer Institute,211,10.1093/jnci/86.19.1458,United States,Article,Houston,0,Journal,2-s2.0-0028143201
Reichel M.,,p53 mutations in primary human lung tumors and their metastases,1994,Molecular Carcinogenesis,57,10.1002/mc.2940090208,Switzerland,Article,Zurich,0,Journal,2-s2.0-0028217247
Ory K.,,Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation,1994,EMBO Journal,225,10.1002/j.1460-2075.1994.tb06656.x,France,Article,Paris,1,Journal,2-s2.0-0027994037
Fujiwara T.,,Induction of Chemosensitivity in Human Lung Cancer Cells in Vivo by Adenovirus-mediated Transfer of the Wild-Type p53 Gene,1994,Cancer Research,485,,,Article,,0,Journal,2-s2.0-0028231586
Sameshima Y.,,Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma,1992,Oncogene,131,,Japan,Article,Chuo-ku,0,Journal,2-s2.0-0026509652
Miller C.W.,,p53 Mutations in Human Lung Tumors,1992,Cancer Research,176,,Japan;Netherlands;United States,Article,Chuo-ku;Groningen;Los Angeles,0,Journal,2-s2.0-0026683175
Kishimoto Y.,,Aberrations of the p53 Tumor Suppressor Gene in Human Non-Small Cell Carcinomas of the Lung,1992,Cancer Research,190,,Japan,Article,Chuo-ku,0,Journal,2-s2.0-0026673041
D'Amico D.,,High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors,1992,Oncogene,198,,United States,Article,Dallas,0,Journal,2-s2.0-0026508613
Bodner S.,,Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation,1992,Oncogene,295,,United States,Article,Bethesda,0,Journal,2-s2.0-0026609019
Takahashi T.,,The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern,1991,Oncogene,193,,Japan,Article,Nagoya,0,Journal,2-s2.0-0026068396
Hensel C.H.,,Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer,1991,Oncogene,73,,United States,Article,San Antonio,0,Journal,2-s2.0-0025807919
Hollstein M.,,p53 mutations in human cancers,1991,Science,7112,10.1126/science.1905840,France;United States,Article,Lyon;Bethesda,0,Journal,2-s2.0-0025894713
Chiba I.,,"Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer",1990,Oncogene,522,,United States,Article,Bethesda,0,Journal,2-s2.0-0025047766
Koo L.,,Worldwide epidemiological patterns of lung cancer in nonsmokers,1990,International Journal of Epidemiology,147,10.1093/ije/19.Supplement_1.S14,Hong Kong,Article,Hong Kong,0,Journal,2-s2.0-0025182955
Hinds P.,,"Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the ""hot spot"" mutant phenotypes.",1990,Cell growth &amp; differentiation : the molecular biology journal of the American Association for Cancer Research,386,,United States,Article,Princeton,0,Journal,2-s2.0-0025618980
Srivastava S.,,Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome,1990,Nature,965,10.1038/348747a0,United States,Article,Bethesda,0,Journal,2-s2.0-0025648762
Takahashi T.,,p53: A frequent target for genetic abnormalities in lung cancer,1989,Science,999,10.1126/science.2554494,United States,Article,Bethesda,0,Journal,2-s2.0-0024452546
Li F.P.,,A Cancer Family Syndrome in Twenty-four Kindreds,1988,Cancer Research,989,,United States,Article,Bethesda,0,Journal,2-s2.0-0023715595
Lane D.,,T antigen is bound to a host protein in SY40-transformed cells [19],1979,Nature,1633,10.1038/278261a0,United States;United Kingdom,Letter,Cold Spring Harbor;London,0,Journal,2-s2.0-0018348655
Melero J.,,Identification of new polypeptide species (48-55K) immunoprecipitable by antiserum to purified large T antigen and present in SV40-infected and -transformed cells,1979,Virology,86,10.1016/0042-6822(79)90250-2,United States,Article,New York,0,Journal,2-s2.0-0018348936
Kress M.,,Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum,1979,Journal of Virology,181,10.1128/jvi.31.2.472-483.1979,France,Article,Villejuif,1,Journal,2-s2.0-0018769971
Linzer D.,,Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells,1979,Cell,1150,10.1016/0092-8674(79)90293-9,United States,Article,Princeton,0,Journal,2-s2.0-0018760324
Doll R.,,Mortality in Relation to Smoking: Ten Years' Observations of British Doctors,1964,British Medical Journal,157,10.1136/bmj.1.5396.1460,United Kingdom,Article,London,1,Journal,2-s2.0-75549113670
